When people consider what causes high blood pressure, they often think of lifestyle factors, such as eating salty foods, lack of exercise or smoking. However, an unexpected source of salt might also ...
Designed to expand treatment options for patients with cirrhosis and complications of portal hypertension, this ...
BD (Becton, Dickinson and Company) announced European CE Mark approval for the Liverty transjugular intrahepatic portosystemic sh ...
Background Neutrophils guarantee a prompt and robust host response to pathogens. Yet, overshooting neutrophil activation ...
BDX seeks CE Mark for its Liverty TIPS Stent Graft, a next-gen device aimed at improving portal hypertension treatment and ...
The cervical biopsy was nondiagnostic despite imaging and PET suggesting aggressive disease; a targeted lumbar biopsy ...
Franklin Lakes, New Jersey-based BD designed the stent graft to expand treatment options for patients with cirrhosis and ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced application of ...
Antivirals given for chronic hepatitis B include nucleos(t)ide analog monotherapy and pegylated interferon-alpha therapy, but ...
The Company will present new NAVIGATE trial analyses at EASL 2026 (May 27–30, 2026), including an oral presentation on reduced varices based on favorable changes in markers of fibrosis formation and ...
A new review highlights how combining multiple ultrasound techniques may help detect and assess portal hypertension in liver cirrhosis BERN, CANTON OF BERN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results